Fryderyk M. Lorenz
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.
Journal: Genes, chromosomes & cancer
Published: September 05, 2024
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes.
Journal: Journal of internal medicine
Published: April 24, 2024
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Journal: Haematologica
Published: September 29, 2021
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Journal: Transplantation and cellular therapy
Published: March 26, 2021
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study.
Journal: Leukemia & lymphoma
Published: March 15, 2021
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Journal: Genes, chromosomes & cancer
Published: November 24, 2020
Fever in systemic lupus erythematosus: disease exacerbation or infection?
Journal: Zeitschrift fur Rheumatologie
Published: March 30, 2020
Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
Journal: British journal of haematology
Published: March 06, 2020
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years.
Journal: British journal of haematology
Published: October 06, 2019
Last Updated: 09/26/2026